Circulating Tumor Cells in Glioblastoma

Area of Science:

• Neuro-oncology
• Cancer Biology
• Molecular Diagnostics

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor with a historically poor prognosis.
• GBM was traditionally considered non-metastatic, but recent findings of circulating tumor cells (CTCs) challenge this paradigm.
• The detection of CTCs in GBM opens new possibilities for liquid biopsy in neuro-oncology.

Purpose of the Study:

• To review the current understanding of glioblastoma CTCs.
• To highlight their unique characteristics, detection methods, and challenges.
• To explore their potential in personalized glioblastoma management.

Main Methods:

• Review of current literature on glioblastoma CTCs.
• Analysis of detection technologies and their limitations.
• Comparison of GBM CTCs with those from extracranial cancers.

Main Results:

• GBM CTCs possess unique properties and face challenges like rarity and the blood-brain barrier.
• Specialized enrichment techniques are necessary for their detection.
• CTC analysis provides insights into tumor heterogeneity, treatment response, and minimal residual disease.

Conclusions:

• Circulating tumor cells in glioblastoma offer valuable information for dynamic tumor surveillance.
• Emerging clinical studies show promise for early relapse detection and therapy monitoring.
• Integrating CTC analysis with other liquid biopsy methods can transform glioblastoma management and improve patient outcomes.